Related Experiment Videos
Insights
High cholesterol (hypercholesterolemia) is a key cause of early atherosclerosis. Understanding foam cell development from monocytes offers new ways to slow this artery disease.
Area of Science:
- Cardiovascular Science
- Pathology
- Molecular Biology
Background:
- Hypercholesterolemia is increasingly recognized as a significant cause of premature atherosclerosis.
- Familial hypercholesterolemia, linked to low-density lipoprotein receptor deficiency, provides strong evidence for this link.
- While not the sole cause, high cholesterol is a determining factor in many atherosclerosis cases.
Purpose of the Study:
- To review mechanisms by which hypercholesterolemia accelerates atherogenesis.
- To detail the role of the foam cell in early atherosclerotic lesions (fatty streaks).
- To explore new insights into foam cell biology and potential therapeutic interventions.
Main Methods:
- Review of current scientific literature and hypotheses.
- Detailed discussion of foam cell origins and characteristics.
- Analysis of recent studies on macrophage-derived foam cell biology.
Main Results:
- Hypercholesterolemia can be a direct cause of premature atherosclerosis.
- Foam cells, originating largely from monocytes, are central to early atherosclerotic lesions.
- Understanding foam cell interactions with lipoproteins provides new insights into atherogenesis.
Conclusions:
- Hypercholesterolemia is a critical driver of atherosclerosis.
- Foam cell biology, particularly its monocyte origin, is key to understanding disease progression.
- Further research into foam cell mechanisms may lead to novel therapies to slow atherosclerosis, complementing cholesterol-lowering strategies.
Abstract:
It is now clear that hypercholesterolemia can, in some instances, be a necessary and sufficient cause of premature atherosclerosis. This has been best established in patients with familial hypercholesterolemia, a deficiency of the low-density lipoprotein receptor. Although hypercholesterolemia is not the only cause of atherosclerosis, a large body of evidence has identified it as a determining cause in many cases. This article reviews current hypotheses regarding the mechanisms by which hypercholesterolemia accelerates atherogenesis. The role of the foam cell is discussed in detail because it is a characteristic feature of the earliest lesion, the so-called fatty streak. Once thought to derive exclusively from smooth muscle cells, the foam cell is now known to originate in large part from monocytes that enter the artery wall and alter their properties to become tissue macrophages. Recent studies of the biology of the macrophage-derived foam cell are providing new insights into the mechanisms by which it enters the arterial wall and interacts with various classes of native and modified lipoproteins. As our understanding of the biology of the foam cell and its precursors grows, it may become possible to intervene and slow the progress of atherosclerosis by new modalities that might act synergistically with measures to control plasma cholesterol levels.